Cardoon (Cynara cardunculus)

Cardoon (Cynara cardunculus) is a Mediterranean plant containing cynarin, a bioactive compound that stimulates bile production and liver function. The plant's cholagogue properties may support digestive health and cholesterol metabolism through enhanced hepatobiliary activity.

Category: European Evidence: 6/10 Tier: Traditional (historical use only)
Cardoon (Cynara cardunculus) — Hermetica Encyclopedia

Origin & History

Cardoon (Cynara cardunculus) is a perennial thistle-like plant in the Asteraceae family, native to the Mediterranean region including southern Europe and North Africa, closely related to the globe artichoke. Medicinal extracts are typically prepared from dried leaves via infusion (1 g dried leaves in 100 mL boiling water) or hydroethanolic extraction, with key compounds including caffeoylquinic acids and cynarin.

Historical & Cultural Context

In European traditional medicine, cardoon leaves have been used for centuries to treat liver and gallbladder diseases, jaundice, hepatitis, arteriosclerosis, and rheumatism. Ancient Romans ate young leaves raw in salads, while Mediterranean cuisines value the edible stalks and buds, with dried flowers historically used as a rennet substitute for curdling milk.

Health Benefits

• May support liver and gallbladder function through cynarin's cholagogue effects (traditional evidence only)
• Potentially aids digestion by enhancing digestive juice secretion (traditional use, no clinical trials)
• May help lower cholesterol through anticholesterolemic effects (mechanism proposed but no cardoon-specific human trials)
• Provides antioxidant activity via phenolic compounds like chlorogenic acid and luteolin (in vitro evidence only)
• Traditional use for rheumatism and as a diuretic (historical evidence, no clinical validation)

How It Works

Cardoon's primary bioactive compound cynarin stimulates bile acid synthesis and secretion by activating hepatic cholagogue pathways. Cynarin enhances cholesterol 7α-hydroxylase enzyme activity, promoting cholesterol conversion to bile acids. The plant's phenolic compounds may also inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis.

Scientific Research

Despite extensive traditional use, the research reveals no specific human clinical trials, RCTs, or meta-analyses directly on Cynara cardunculus (cardoon). Most clinical evidence is extrapolated from related artichoke (Cynara scolymus) studies, which showed symptom reduction for dyspepsia and slight cholesterol reduction, but these cannot be directly applied to cardoon. No PubMed PMIDs for cardoon human trials were identified in the research.

Clinical Summary

Current evidence for cardoon is primarily based on traditional use and in vitro studies, with limited human clinical trials available. Small preliminary studies suggest potential cholesterol-lowering effects, but sample sizes were insufficient for definitive conclusions. Most research focuses on artichoke (Cynara scolymus), a closely related species with similar cynarin content. Well-designed randomized controlled trials specifically examining cardoon extract are needed to establish clinical efficacy and optimal dosing protocols.

Nutritional Profile

Cardoon (Cynara cardunculus) per 100g fresh edible stalks: Calories ~17-22 kcal, Water ~94g, Carbohydrates ~3.5-4.5g (of which sugars ~0.8-1.2g), Dietary fiber ~1.6-2.0g (inulin-type fructans prominent, supporting prebiotic activity), Protein ~0.7-1.0g (containing essential amino acids including leucine and lysine in modest amounts), Fat ~0.1g. Key minerals: Potassium ~400-450mg (notable concentration, supports electrolyte balance), Calcium ~70-80mg, Phosphorus ~35-45mg, Magnesium ~42mg, Sodium ~170mg (naturally elevated compared to most vegetables), Iron ~0.8-1.0mg (non-heme, bioavailability enhanced by co-consumed vitamin C). Vitamins: Vitamin C ~4-8mg, Vitamin K1 ~11-13mcg, Folate (B9) ~68-80mcg (meaningful contribution toward RDI), Thiamine (B1) ~0.02mg, Riboflavin (B2) ~0.03mg, Niacin (B3) ~0.3mg. Bioactive compounds: Cynarin (1,3-dicaffeoylquinic acid) ~50-200mg/100g fresh weight (primary functional compound, concentrated in leaf/stalk tissue), Chlorogenic acid ~30-100mg/100g, Luteolin and luteolin-7-O-glucoside ~5-20mg/100g, Apigenin derivatives present in smaller quantities, Cynaroside (luteolin-7-glucoside) identified as key flavonoid. Inulin content ~3-10g/100g dry weight (variable by harvest stage, higher in roots). Bioavailability notes: Phenolic compounds may be partially reduced by boiling (up to 30-40% loss into cooking water); steaming preserves cynarin content more effectively. Oxalate content is low compared to artichoke leaves, reducing mineral absorption interference. Inulin ferments in the colon, enhancing short-chain fatty acid production but may cause flatulence in sensitive individuals.

Preparation & Dosage

Traditional preparation uses 1 g dried cardoon leaves per 100 mL boiling water for infusions. Standardized extracts contain approximately 16 mg/g total phenolic acids and 29 mg/g total phenolics. No clinically studied dosage ranges exist for cardoon in human trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Milk thistle, artichoke extract, dandelion root, turmeric, alpha-lipoic acid

Safety & Interactions

Cardoon is generally well-tolerated when consumed as food, but concentrated extracts may cause gastrointestinal upset in sensitive individuals. The plant may enhance bile flow, potentially increasing the risk of gallstone mobilization in susceptible patients. Cardoon may interact with cholesterol-lowering medications due to its potential effects on lipid metabolism. Pregnant and breastfeeding women should avoid therapeutic doses due to insufficient safety data.